nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—CYP1A1—Thalidomide—leprosy	0.0874	0.104	CbGbCtD
Haloperidol—CYP3A7—Rifampicin—leprosy	0.0678	0.0806	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.0678	0.0806	CbGbCtD
Haloperidol—CYP3A7—Dapsone—leprosy	0.0559	0.0665	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Dapsone—leprosy	0.0559	0.0665	CbGbCtD
Haloperidol—CYP3A5—Thalidomide—leprosy	0.0525	0.0624	CbGbCtD
Haloperidol—CYP3A5—Rifampicin—leprosy	0.0508	0.0604	CbGbCtD
Haloperidol—CYP2C19—Thalidomide—leprosy	0.0423	0.0503	CbGbCtD
Haloperidol—CYP3A5—Dapsone—leprosy	0.042	0.0499	CbGbCtD
Haloperidol—CYP2C19—Rifampicin—leprosy	0.041	0.0487	CbGbCtD
Haloperidol—CYP1A2—Thalidomide—leprosy	0.0391	0.0464	CbGbCtD
Haloperidol—CYP1A2—Rifampicin—leprosy	0.0378	0.045	CbGbCtD
Haloperidol—CYP2C9—Thalidomide—leprosy	0.0352	0.0418	CbGbCtD
Haloperidol—CYP2C9—Rifampicin—leprosy	0.0341	0.0405	CbGbCtD
Haloperidol—CYP2C19—Dapsone—leprosy	0.0338	0.0402	CbGbCtD
Haloperidol—ABCB1—Rifampicin—leprosy	0.0331	0.0393	CbGbCtD
Haloperidol—CYP2C9—Dapsone—leprosy	0.0281	0.0335	CbGbCtD
Haloperidol—CYP3A4—Rifampicin—leprosy	0.0198	0.0236	CbGbCtD
Haloperidol—CYP3A4—Dapsone—leprosy	0.0164	0.0195	CbGbCtD
Haloperidol—HTR1B—trigeminal nerve—leprosy	0.00648	0.0811	CbGeAlD
Haloperidol—HTR1D—trigeminal nerve—leprosy	0.00627	0.0785	CbGeAlD
Haloperidol—GRIN2B—nerve—leprosy	0.00486	0.0609	CbGeAlD
Haloperidol—HRH1—nose—leprosy	0.00475	0.0595	CbGeAlD
Haloperidol—HTR1B—cranial nerve—leprosy	0.00461	0.0578	CbGeAlD
Haloperidol—HTR1D—cranial nerve—leprosy	0.00447	0.0559	CbGeAlD
Haloperidol—HTR2A—trigeminal nerve—leprosy	0.00311	0.039	CbGeAlD
Haloperidol—DRD1—nerve—leprosy	0.00292	0.0365	CbGeAlD
Haloperidol—Parkinsonism—Thalidomide—leprosy	0.00261	0.0331	CcSEcCtD
Haloperidol—Grand mal convulsion—Thalidomide—leprosy	0.00249	0.0316	CcSEcCtD
Haloperidol—HTR2A—cranial nerve—leprosy	0.00222	0.0278	CbGeAlD
Haloperidol—Sexual dysfunction—Thalidomide—leprosy	0.00212	0.0268	CcSEcCtD
Haloperidol—Inappropriate antidiuretic hormone secretion—Thalidomide—leprosy	0.00204	0.0259	CcSEcCtD
Haloperidol—HTR2A—hindlimb—leprosy	0.00187	0.0234	CbGeAlD
Haloperidol—HTR1B—blood vessel—leprosy	0.00186	0.0233	CbGeAlD
Haloperidol—Galactorrhoea—Thalidomide—leprosy	0.00183	0.0232	CcSEcCtD
Haloperidol—HTR1D—blood vessel—leprosy	0.0018	0.0225	CbGeAlD
Haloperidol—Menstrual disorder—Thalidomide—leprosy	0.00174	0.022	CcSEcCtD
Haloperidol—DRD2—nerve—leprosy	0.00172	0.0216	CbGeAlD
Haloperidol—CYP1A1—skin epidermis—leprosy	0.00168	0.0211	CbGeAlD
Haloperidol—Nystagmus—Thalidomide—leprosy	0.00166	0.021	CcSEcCtD
Haloperidol—Psychotic disorder—Dapsone—leprosy	0.00164	0.0208	CcSEcCtD
Haloperidol—HTR2A—appendage—leprosy	0.0016	0.0201	CbGeAlD
Haloperidol—Cholestasis—Thalidomide—leprosy	0.00156	0.0198	CcSEcCtD
Haloperidol—CBR1—eye—leprosy	0.00151	0.0189	CbGeAlD
Haloperidol—HTR2A—peripheral nervous system—leprosy	0.00146	0.0183	CbGeAlD
Haloperidol—Endocrine disorder—Thalidomide—leprosy	0.00143	0.0181	CcSEcCtD
Haloperidol—Amenorrhoea—Thalidomide—leprosy	0.00135	0.0171	CcSEcCtD
Haloperidol—DRD4—testis—leprosy	0.00133	0.0166	CbGeAlD
Haloperidol—Photosensitivity reaction—Dapsone—leprosy	0.00133	0.0168	CcSEcCtD
Haloperidol—Musculoskeletal stiffness—Thalidomide—leprosy	0.00132	0.0168	CcSEcCtD
Haloperidol—CBR1—skin of body—leprosy	0.00131	0.0164	CbGeAlD
Haloperidol—Dyskinesia—Thalidomide—leprosy	0.00126	0.016	CcSEcCtD
Haloperidol—Leukocytosis—Thalidomide—leprosy	0.00126	0.016	CcSEcCtD
Haloperidol—Gait disturbance—Thalidomide—leprosy	0.00122	0.0154	CcSEcCtD
Haloperidol—HTR2A—nerve—leprosy	0.00114	0.0142	CbGeAlD
Haloperidol—GRIN2B—nervous system—leprosy	0.00109	0.0137	CbGeAlD
Haloperidol—H1F0—skin of body—leprosy	0.00107	0.0135	CbGeAlD
Haloperidol—Gynaecomastia—Thalidomide—leprosy	0.00106	0.0134	CcSEcCtD
Haloperidol—Hypertonia—Thalidomide—leprosy	0.00104	0.0132	CcSEcCtD
Haloperidol—Hyperkinesia—Thalidomide—leprosy	0.00104	0.0131	CcSEcCtD
Haloperidol—Euphoric mood—Thalidomide—leprosy	0.00102	0.0129	CcSEcCtD
Haloperidol—CBR1—tendon—leprosy	0.000998	0.0125	CbGeAlD
Haloperidol—Photosensitivity—Thalidomide—leprosy	0.000981	0.0124	CcSEcCtD
Haloperidol—HTR1D—eye—leprosy	0.000957	0.012	CbGeAlD
Haloperidol—Vision blurred—Dapsone—leprosy	0.000955	0.0121	CcSEcCtD
Haloperidol—Libido decreased—Thalidomide—leprosy	0.000929	0.0118	CcSEcCtD
Haloperidol—DRD3—nervous system—leprosy	0.000917	0.0115	CbGeAlD
Haloperidol—Dermatitis exfoliative—Thalidomide—leprosy	0.000913	0.0116	CcSEcCtD
Haloperidol—Vertigo—Dapsone—leprosy	0.000911	0.0115	CcSEcCtD
Haloperidol—Visual disturbance—Thalidomide—leprosy	0.000909	0.0115	CcSEcCtD
Haloperidol—HTR2A—blood vessel—leprosy	0.000893	0.0112	CbGeAlD
Haloperidol—SIGMAR1—eye—leprosy	0.000892	0.0112	CbGeAlD
Haloperidol—Hypoglycaemia—Thalidomide—leprosy	0.000883	0.0112	CcSEcCtD
Haloperidol—Lethargy—Thalidomide—leprosy	0.000879	0.0111	CcSEcCtD
Haloperidol—Hyponatraemia—Thalidomide—leprosy	0.000865	0.011	CcSEcCtD
Haloperidol—Disturbance in sexual arousal—Thalidomide—leprosy	0.000855	0.0108	CcSEcCtD
Haloperidol—Psychotic disorder—Thalidomide—leprosy	0.000841	0.0107	CcSEcCtD
Haloperidol—Face oedema—Thalidomide—leprosy	0.000832	0.0105	CcSEcCtD
Haloperidol—CBR1—testis—leprosy	0.000827	0.0104	CbGeAlD
Haloperidol—Cardiac arrest—Thalidomide—leprosy	0.000819	0.0104	CcSEcCtD
Haloperidol—H1F0—tendon—leprosy	0.000818	0.0102	CbGeAlD
Haloperidol—CBR1—nervous system—leprosy	0.000811	0.0102	CbGeAlD
Haloperidol—Tachycardia—Dapsone—leprosy	0.000807	0.0102	CcSEcCtD
Haloperidol—Liver function test abnormal—Thalidomide—leprosy	0.000795	0.0101	CcSEcCtD
Haloperidol—Orthostatic hypotension—Thalidomide—leprosy	0.000787	0.00996	CcSEcCtD
Haloperidol—Breast disorder—Thalidomide—leprosy	0.000779	0.00986	CcSEcCtD
Haloperidol—HTR2B—skin of body—leprosy	0.000774	0.0097	CbGeAlD
Haloperidol—Insomnia—Dapsone—leprosy	0.000748	0.00947	CcSEcCtD
Haloperidol—Dysphagia—Thalidomide—leprosy	0.000745	0.00943	CcSEcCtD
Haloperidol—Bronchospasm—Thalidomide—leprosy	0.000732	0.00927	CcSEcCtD
Haloperidol—DRD2—eye—leprosy	0.000721	0.00902	CbGeAlD
Haloperidol—Pancytopenia—Thalidomide—leprosy	0.000707	0.00895	CcSEcCtD
Haloperidol—Neutropenia—Thalidomide—leprosy	0.000696	0.00882	CcSEcCtD
Haloperidol—Erectile dysfunction—Thalidomide—leprosy	0.000686	0.00868	CcSEcCtD
Haloperidol—Photosensitivity reaction—Thalidomide—leprosy	0.00068	0.00861	CcSEcCtD
Haloperidol—Weight increased—Thalidomide—leprosy	0.000678	0.00858	CcSEcCtD
Haloperidol—H1F0—testis—leprosy	0.000677	0.00848	CbGeAlD
Haloperidol—Weight decreased—Thalidomide—leprosy	0.000674	0.00853	CcSEcCtD
Haloperidol—Hyperglycaemia—Thalidomide—leprosy	0.000672	0.0085	CcSEcCtD
Haloperidol—H1F0—nervous system—leprosy	0.000665	0.00832	CbGeAlD
Haloperidol—Drowsiness—Thalidomide—leprosy	0.000664	0.00841	CcSEcCtD
Haloperidol—Depression—Thalidomide—leprosy	0.000662	0.00838	CcSEcCtD
Haloperidol—DRD1—nervous system—leprosy	0.000656	0.00822	CbGeAlD
Haloperidol—Body temperature increased—Dapsone—leprosy	0.000654	0.00828	CcSEcCtD
Haloperidol—Agranulocytosis—Thalidomide—leprosy	0.00062	0.00785	CcSEcCtD
Haloperidol—Hepatitis—Thalidomide—leprosy	0.000596	0.00755	CcSEcCtD
Haloperidol—SIGMAR1—tendon—leprosy	0.000591	0.0074	CbGeAlD
Haloperidol—HTR2B—tendon—leprosy	0.000589	0.00738	CbGeAlD
Haloperidol—Urinary tract disorder—Thalidomide—leprosy	0.000589	0.00745	CcSEcCtD
Haloperidol—ABCB1—blood vessel—leprosy	0.000585	0.00733	CbGeAlD
Haloperidol—Urethral disorder—Thalidomide—leprosy	0.000584	0.0074	CcSEcCtD
Haloperidol—Visual impairment—Thalidomide—leprosy	0.000574	0.00727	CcSEcCtD
Haloperidol—HRH1—eye—leprosy	0.000569	0.00713	CbGeAlD
Haloperidol—Eye disorder—Thalidomide—leprosy	0.000557	0.00705	CcSEcCtD
Haloperidol—Cardiac disorder—Thalidomide—leprosy	0.000553	0.007	CcSEcCtD
Haloperidol—Angiopathy—Thalidomide—leprosy	0.000541	0.00685	CcSEcCtD
Haloperidol—Immune system disorder—Thalidomide—leprosy	0.000538	0.00682	CcSEcCtD
Haloperidol—Mediastinal disorder—Thalidomide—leprosy	0.000537	0.0068	CcSEcCtD
Haloperidol—HTR1B—nervous system—leprosy	0.000532	0.00666	CbGeAlD
Haloperidol—Alopecia—Thalidomide—leprosy	0.000527	0.00667	CcSEcCtD
Haloperidol—Vomiting—Dapsone—leprosy	0.000526	0.00666	CcSEcCtD
Haloperidol—Mental disorder—Thalidomide—leprosy	0.000522	0.00661	CcSEcCtD
Haloperidol—CYP1A1—skin of body—leprosy	0.000522	0.00653	CbGeAlD
Haloperidol—Malnutrition—Thalidomide—leprosy	0.000519	0.00657	CcSEcCtD
Haloperidol—Headache—Dapsone—leprosy	0.000518	0.00656	CcSEcCtD
Haloperidol—HTR1D—nervous system—leprosy	0.000515	0.00645	CbGeAlD
Haloperidol—Muscle spasms—Thalidomide—leprosy	0.000499	0.00632	CcSEcCtD
Haloperidol—Nausea—Dapsone—leprosy	0.000491	0.00622	CcSEcCtD
Haloperidol—SIGMAR1—testis—leprosy	0.000489	0.00613	CbGeAlD
Haloperidol—Vision blurred—Thalidomide—leprosy	0.000489	0.00619	CcSEcCtD
Haloperidol—Tremor—Thalidomide—leprosy	0.000486	0.00615	CcSEcCtD
Haloperidol—Anaemia—Thalidomide—leprosy	0.00048	0.00607	CcSEcCtD
Haloperidol—HTR2B—nervous system—leprosy	0.000479	0.006	CbGeAlD
Haloperidol—Agitation—Thalidomide—leprosy	0.000477	0.00604	CcSEcCtD
Haloperidol—HTR2A—eye—leprosy	0.000475	0.00595	CbGeAlD
Haloperidol—Vertigo—Thalidomide—leprosy	0.000466	0.0059	CcSEcCtD
Haloperidol—Leukopenia—Thalidomide—leprosy	0.000464	0.00588	CcSEcCtD
Haloperidol—Convulsion—Thalidomide—leprosy	0.00045	0.00569	CcSEcCtD
Haloperidol—Hypertension—Thalidomide—leprosy	0.000448	0.00567	CcSEcCtD
Haloperidol—Anxiety—Thalidomide—leprosy	0.00044	0.00557	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000439	0.00555	CcSEcCtD
Haloperidol—Dry mouth—Thalidomide—leprosy	0.000432	0.00547	CcSEcCtD
Haloperidol—Confusional state—Thalidomide—leprosy	0.000427	0.00541	CcSEcCtD
Haloperidol—Oedema—Thalidomide—leprosy	0.000423	0.00536	CcSEcCtD
Haloperidol—Nervous system disorder—Thalidomide—leprosy	0.000415	0.00526	CcSEcCtD
Haloperidol—Thrombocytopenia—Thalidomide—leprosy	0.000415	0.00525	CcSEcCtD
Haloperidol—Tachycardia—Thalidomide—leprosy	0.000413	0.00523	CcSEcCtD
Haloperidol—Skin disorder—Thalidomide—leprosy	0.000411	0.00521	CcSEcCtD
Haloperidol—Hyperhidrosis—Thalidomide—leprosy	0.000409	0.00518	CcSEcCtD
Haloperidol—Anorexia—Thalidomide—leprosy	0.000404	0.00511	CcSEcCtD
Haloperidol—Hypotension—Thalidomide—leprosy	0.000396	0.00501	CcSEcCtD
Haloperidol—DRD2—testis—leprosy	0.000395	0.00495	CbGeAlD
Haloperidol—KCNH2—testis—leprosy	0.000389	0.00488	CbGeAlD
Haloperidol—DRD2—nervous system—leprosy	0.000388	0.00486	CbGeAlD
Haloperidol—Insomnia—Thalidomide—leprosy	0.000383	0.00485	CcSEcCtD
Haloperidol—KCNH2—nervous system—leprosy	0.000382	0.00479	CbGeAlD
Haloperidol—Dyspnoea—Thalidomide—leprosy	0.000377	0.00478	CcSEcCtD
Haloperidol—HRH1—tendon—leprosy	0.000377	0.00472	CbGeAlD
Haloperidol—Somnolence—Thalidomide—leprosy	0.000376	0.00477	CcSEcCtD
Haloperidol—Dyspepsia—Thalidomide—leprosy	0.000373	0.00472	CcSEcCtD
Haloperidol—Decreased appetite—Thalidomide—leprosy	0.000368	0.00466	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Thalidomide—leprosy	0.000366	0.00463	CcSEcCtD
Haloperidol—Constipation—Thalidomide—leprosy	0.000362	0.00458	CcSEcCtD
Haloperidol—Feeling abnormal—Thalidomide—leprosy	0.000349	0.00442	CcSEcCtD
Haloperidol—Urticaria—Thalidomide—leprosy	0.000336	0.00426	CcSEcCtD
Haloperidol—Body temperature increased—Thalidomide—leprosy	0.000335	0.00424	CcSEcCtD
Haloperidol—CYP1A1—nervous system—leprosy	0.000323	0.00404	CbGeAlD
Haloperidol—HTR2A—tendon—leprosy	0.000315	0.00394	CbGeAlD
Haloperidol—HRH1—testis—leprosy	0.000312	0.00391	CbGeAlD
Haloperidol—Hypersensitivity—Thalidomide—leprosy	0.000312	0.00395	CcSEcCtD
Haloperidol—HRH1—nervous system—leprosy	0.000306	0.00384	CbGeAlD
Haloperidol—Pruritus—Thalidomide—leprosy	0.0003	0.00379	CcSEcCtD
Haloperidol—Diarrhoea—Thalidomide—leprosy	0.00029	0.00367	CcSEcCtD
Haloperidol—Dizziness—Thalidomide—leprosy	0.00028	0.00355	CcSEcCtD
Haloperidol—Vomiting—Thalidomide—leprosy	0.000269	0.00341	CcSEcCtD
Haloperidol—Rash—Thalidomide—leprosy	0.000267	0.00338	CcSEcCtD
Haloperidol—Dermatitis—Thalidomide—leprosy	0.000267	0.00338	CcSEcCtD
Haloperidol—Headache—Thalidomide—leprosy	0.000265	0.00336	CcSEcCtD
Haloperidol—HTR2A—testis—leprosy	0.000261	0.00326	CbGeAlD
Haloperidol—HTR2A—nervous system—leprosy	0.000256	0.0032	CbGeAlD
Haloperidol—Nausea—Thalidomide—leprosy	0.000252	0.00318	CcSEcCtD
Haloperidol—CYP2D6—testis—leprosy	0.000237	0.00297	CbGeAlD
Haloperidol—CYP3A4—nervous system—leprosy	0.000237	0.00297	CbGeAlD
Haloperidol—CYP2D6—nervous system—leprosy	0.000233	0.00292	CbGeAlD
Haloperidol—ABCB1—testis—leprosy	0.000171	0.00214	CbGeAlD
Haloperidol—ABCB1—nervous system—leprosy	0.000168	0.0021	CbGeAlD
